GlassScriptPhysician profile
Anthony J Infante
NPI 1124131271
$1,703.12
in general payments reported to CMS, 2019-2025
18 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Pediatric Allergy/Immunology provider received nationally (typical 2025 total: $375).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $45.96 · 2021: $125 · 2022: $225 · 2023: $302 · 2024: $156 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $337.22 | 2022-2025 | Hizentra |
| Jazz Pharmaceuticals INC. | $163.46 | 2023-2025 | |
| Amgen INC. | $151.41 | 2019-2022 | |
| Horizon Therapeutics Plc | $125.00 | 2021 | |
| Biogen, INC. | $122.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $120.44 | 2019 | |
| Alexion Pharmaceuticals, INC. | $116.85 | 2019 | |
| Servier Pharmaceuticals LLC | $113.66 | 2020-2025 | |
| Sanofi Pasteur INC. | $95.78 | 2024-2025 | |
| Pfizer INC. | $80.32 | 2019 | |
| Grifols USA, LLC | $73.87 | 2023-2025 | Xembify |
| Rhythm Pharmaceuticals, INC. | $63.89 | 2022 | |
| Kerecis Limited | $28.98 | 2020 | |
| Syndax Pharmaceuticals, INC. | $27.71 | 2025 | |
| Photocure INC | $23.88 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $22.90 | 2024 | Iwilfin |
| Kyowa Kirin, INC. | $18.40 | 2025 | |
| Karl Storz Endoscopy-America | $17.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Infante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.